Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.37 |
| ▸ | NQO2 | P16083 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | MITF | O75030 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30837586 | 1.00 | CA1 (0.43) | CA1CA2KDM4EMAPTALDH1A1 | |
| Oxalic Acid SCHEMBL1252610 | 0.89 | ALDH1A1 (0.46) | CA1CA2KDM4EMAPTALDH1A1 | |
| Succinic Acid SCHEMBL1251838 | 0.84 | KDM4E (0.46) | KDM4EMAPTALDH1A1SMN1; SMN2MAPK1 | |
| Maleic Acid SCHEMBL1250309 | 0.84 | ALDH1A1 (0.42) | KDM4EMAPTALDH1A1LMNAGAA | |
| Fumaric Acid SCHEMBL1250313 | 0.84 | ALDH1A1 (0.42) | KDM4EMAPTALDH1A1LMNAGAA | |
| Cadaverine Tartrate SCHEMBL1251771 | 0.82 | MAPK1 (0.41) | KDM4EMAPTALDH1A1LMNAGAA | |
| SCHEMBL8814883 | 0.79 | SELL (0.43) | CA1CA2KDM4EMAPTALDH1A1 | |
| SCHEMBL24529687 | 0.75 | MAPT (0.46) | MAPTALDH1A1LMNASMN1; SMN2MAPK1 | |
| SCHEMBL21851374 | 0.75 | VRK1 (0.41) | KDM4EMAPTLMNAGAAPOLB | |
| SCHEMBL25111458 | 0.75 | CA1 (0.40) | CA1CA2KDM4EMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117757523-A | Multi-component scale inhibitor and method for preventing scale in petrochemical production | 江苏太湖新材料技术研发有限公司 | 2024-03-26 | — | — | CN | claimed |
| US-8044210-B2 | Substance having antioxidant, geroprotective and anti-ischemic activity and method for the preparation thereof | MARVEL LIFESCIENCES LIMITED (GB) | 2011-10-25 | — | — | US | claimed |
| US-20110045065-A1 | SUBSTANCE HAVING ANTIOXIDANT, GEROPROTECTIVE AND ANTI-ISCHEMIC ACTIVITY AND METHOD FOR THE PREPARATION THEREOF | MARVEL LIFE SCIENCES LTD. (GB) | 2011-02-24 | — | — | US | claimed |
| EP-2265253-A2 | ORAL DOSAGE FORM CONTAINING A PYRIDINOL DERIVATIVE | Marvel Lifesciences Limited (GB) | 2010-12-29 | — | — | EP | claimed |
| EP-2265252-A2 | OPHTHALMIC PREPARATION CONTAINING A PYRIDINOL DERIVATE | Marvel Lifesciences Limited (GB) | 2010-12-29 | — | — | EP | claimed |
| EP-2252265-A2 | INJECTABLE PREPARATIONS AND A PROCESS OF PREPARATION THEREOF | Marvel Lifesciences Limited (GB) | 2010-11-24 | — | — | EP | claimed |
| WO-2009116077-A2 | INJECTABLE PREPARATIONS AND A PROCESS OF PREPARATION THEREOF | M.J.BIOPHARM PVT. LTD. (IN) | 2009-09-24 | — | — | WO | claimed |
| WO-2009116076-A2 | STERILE OPTHALMIC PREPARATIONS AND A PROCESS FOR PREPARATION THEREOF | M. J. BIOPHARM PVT.LTD. (IN) | 2009-09-24 | — | — | WO | claimed |
| WO-2009116078-A2 | ORAL DOSAGE FORMULATIONS AND PROCESS OF PREPARATION THEREOF | M. J. BIOPHARM PVT. LTD. (IN) | 2009-09-24 | — | — | WO | claimed |
| EP-1911746-B1 | THE SUBSTANCE HAVING ANTIOXIDANT, GEROPROTECTIVE AND ANTI-ISCHEMIC ACTIVITY AND METHOD FOR PREPARING THEREOF | MARVEL LIFESCIENCES LTD (GB) | 2009-08-26 | — | — | EP | claimed |
| US-20090198068-A1 | SUBSTANCE HAVING ANTIOXIDANT, GEROPROTECTIVE AND ANTI-ISCHEMIC ACTIVITY AND METHOD FOR THE PREPARATION THEREOF | MARVEL LIFESCIENCES LIMITED (GB) | 2009-08-06 | — | — | US | claimed |
| EP-1911746-A1 | THE SUBSTANCE HAVING ANTIOXIDANT, GEROPROTECTIVE AND ANTI-ISCHEMIC ACTIVITY AND METHOD FOR PREPARING THEREOF | Marvel Lifesciences Limited (GB) | 2008-04-16 | — | — | EP | claimed |
| EP-1608326-A2 | EFFICIENT OXIDATIVE HAIR PREPARATION COMPRISING FIBER STRUCTURE STABILIZATION BY MEANS OF RADICAL INTERCEPTORS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2005-12-28 | — | — | EP | claimed |
| WO-2004087086-A2 | EFFICIENT OXIDATIVE HAIR PREPARATION COMPRISING FIBER STRUCTURE STABILIZATION BY MEANS OF RADICAL INTERCEPTORS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2004-10-14 | — | — | WO | claimed |
| US-4578439-A | Styryl pyridine cyanates, styryl pyrazine cyanates and polymers thereof | THE DOW CHEMICAL COMPANY (US) | 1986-03-25 | — | — | US | claimed |
| WO-2025151724-A1 | PYRIDINYLOXYPYRIDINES AS MODULATORS OF ATP -BINDING CASSETTE TRANSPORTERS AND THEIR USE IN TREATING MEDICAL CONDITIONS | RECTIFY PHARMACEUTICALS, INC. (US) | 2025-07-17 | — | — | WO | disclosed |
| US-20250228835-A1 | PYRIDINYLOXYPYRIDINES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | RECTIFY PHARMACEUTICALS, INC. | 2025-07-17 | — | — | US | disclosed |
| US-4578439-A | Styryl pyridine cyanates, styryl pyrazine cyanates and polymers thereof | THE DOW CHEMICAL COMPANY (US) | 1986-03-25 | — | — | US | disclosed |
| US-4540745-A | Allyl styryl pyridines and pyrazines and polymers thereof | THE DOW CHEMICAL COMPANY (US) | 1985-09-10 | — | — | US | disclosed |
| US-4539377-A | HEAT RESISTANCE | THE DOW CHEMICAL COMPANY (US) | 1985-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110045065-A1 | SUBSTANCE HAVING ANTIOXIDANT, GEROPROTECTIVE AND ANTI-ISCHEMIC ACTIVITY AND METHOD FOR THE PREPARATION THEREOF | GPX4, PGC, GSR | CA1 3648/4885CA2 3323/4885KDM4E 2635/4885 |
| US-20090198068-A1 | SUBSTANCE HAVING ANTIOXIDANT, GEROPROTECTIVE AND ANTI-ISCHEMIC ACTIVITY AND METHOD FOR THE PREPARATION THEREOF | GPX4, GPX1, HMOX1 | CA1 968/4885CA2 1549/4885KDM4E 4214/4885 |
| US-20250228835-A1 | PYRIDINYLOXYPYRIDINES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | P2RY6, P2RY4, PNPO | CA1 4825/4885CA2 1969/4885KDM4E 3462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.